ICLA Stock Overview
Manufactures and sells bipolar flow plates for hydrogen fuel cells in Sweden, Europe, North America, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Cell Impact AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.011 |
| 52 Week High | SEK 0.08 |
| 52 Week Low | SEK 0.003 |
| Beta | 1.42 |
| 11 Month Change | 6.00% |
| 3 Month Change | -42.08% |
| 1 Year Change | -78.80% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| ICLA | DE Machinery | DE Market | |
|---|---|---|---|
| 7D | -1.9% | -0.2% | 0.8% |
| 1Y | -78.8% | 19.9% | 9.1% |
Return vs Industry: ICLA underperformed the German Machinery industry which returned 19.9% over the past year.
Return vs Market: ICLA underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| ICLA volatility | |
|---|---|
| ICLA Average Weekly Movement | 115.6% |
| Machinery Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ICLA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: ICLA's weekly volatility has decreased from 125% to 116% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 40 | Daniel Vallin | www.cellimpact.com |
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells in Sweden, Europe, North America, Asia, and internationally. The company offers plates with and precise flow patterns. It serves hydrogen fuel cells producers.
Cell Impact AB (publ) Fundamentals Summary
| ICLA fundamental statistics | |
|---|---|
| Market cap | €10.97m |
| Earnings (TTM) | -€8.64m |
| Revenue (TTM) | €3.17m |
3.5x
P/S Ratio-1.3x
P/E RatioIs ICLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICLA income statement (TTM) | |
|---|---|
| Revenue | SEK 36.53m |
| Cost of Revenue | SEK 29.18m |
| Gross Profit | SEK 7.35m |
| Other Expenses | SEK 107.04m |
| Earnings | -SEK 99.68m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 20.12% |
| Net Profit Margin | -272.87% |
| Debt/Equity Ratio | 6.9% |
How did ICLA perform over the long term?
See historical performance and comparison